Cory berkland.

Cory Berkland, PhD, is the Solon E Summerfield Distinguished Professor at the University of Kansas, US. He is a co-founder and was Chief Scientific Officer of Orbis Biosciences (now Adare Pharmaceuticals) amongst other companies including Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Professor Berkland has a PhD in Chemical and ...Inventors: Stephen J Johnson, Cory Berkland, Ahmad Moradi-Araghi, Jenn-Tai Liang, Terry M. Christian, Riley B. Needham, Min Cheng, Ying-Ying Lin, Andrew B. Woodside Taste masking drug formulations Patent number: 11026893That effort led to an NIH grant with Cory Berkland, Ph.D., of the University of Kansas, as principal investigator. Flash forward to present day and Detamore is a principal investigator of this current NIH project. Berkland, Dr. Brian Andrews, a surgeon who specializes in head and neck surgery at the University of Iowa Hospitals and Clinics, and ...Lianjun Shi 1 , Cory Berkland. Affiliation 1 Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, KS 66047. PMID: 18797513 PMCID: PMC2537468 DOI: 10.1021/ma070443o Abstract Hollow nanoparticles represent an emerging area of development for the encapsulation of active ingredients. ...Cory Plock was the best professor I had while completing a MS in Computer Science at NYU. He introduced programming languages with a tremendous amount of expertise and compassion. His assignments and exams were very challenging, yet he consistently went above and beyond to provide support, giving guidance and detailed feedback. Thank you, Cory!

About. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a partial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development and clinical trial progression of BBI-001.Chittasupho C, Xie S-X, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences. 2009; 37:141-150. [PMC free article] [Google Scholar]

Cory J Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, USA. Department of Pharmaceutical Chemistry, University of Kansas ...Cory Berkland PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 View All People contact info: Email: [email protected] The Berkland lab focuses on developing new therapeutics and biomaterials for improving human health

Multidisciplinary Research Building, room #320D. Learned Hall, room #4160C. [email protected] Author. Cory Berkland. [email protected]; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66047 USA. E-mail: [email protected]; [email protected] Search for more papers by this authorCory Berkland The University of Kansas Verified email at ku.edu. Ayusman Sen Verne M. Willaman Professor of Chemistry, ... CJ Berkland, P Dhar. Langmuir 31 (14), 4232-4245, 2015. 34: 2015: A nondestructive tool for nanomaterials: Raman and photoluminescence spectroscopy. A Singha, P Dhar, A Roy. American journal of physics 73 (3), 224-233, 2005 ...See Free Details & Reputation Profile for Cory Berkland (47) in Lawrence, KS. Includes free contact info & photos & court records.Cory Berkland PhD, University of Illinois, 2003 MS, University of Illinois, 2001 BS, Iowa State University, 1998 View All People contact info: Email: [email protected] The Berkland lab focuses on developing new therapeutics and biomaterials for improving human health

Cory Berkland. Solon E. Summerfield Distinguished Professor. PHARMACEUTICAL CHEMISTRY. Contact Info. 785-864-1455. Multidisciplinary Research Building, Room …

Cory Berkland. The University of Kansas. Verified email at ku.edu. Drug Delivery Formulation Controlled Release. Articles Cited by Public access Co ... YY Lin, M Laird …

About. My PhD work in Bioengineering at the University of Kansas was performed under the advisement of Dr. Cory Berkland. My research entails the fabrication and validation of a high throughput ...Cory Berkland. Professor Cory Berkland's lab continues to bridge research in Pharmaceutical Chemistry, Chemical Engineering, and Bioengineering at KU. The lab recently completed a research collaboration with Orion BioScience sponsored by the Juvenile Diabetes Research Foundation aiming to prevent the progression of Type 1 Diabetes using ...Cory Berkland & Daniel W. Pack. Department of Electrical and Computer Engineering, University of Illinois, Urbana, Illinois, 61801. Kyekyoon (Kevin) Kim. Authors. Cory Berkland. View author publications. You can also search for this author in PubMed Google ...Cory Berkland, Solon E. Summerfield Distinguished Professor; Stevin Gehrke, Fred Kurata Memorial Professor; Trung Van Nguyen, professor; Mark Shiflett, Foundation Distinguished Professor; Bala Subramaniam, Dan F. Servey Distinguished Professor; Civil, environmental & architectural engineering. David Darwin, Deane E. Ackers Distinguished ProfessorCory Berkland, PhD He will be starting as a Professor in the Biomedical Engineering Department and the Chemistry Department at Washington University, Fall 2023. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering ...By Akihisa Nonoyama, Ph.D., Nathan Dormer, Ph.D., and Cory Berkland, Ph.D., Adare Pharma Solutions Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. An alternate presentation of the drug in the form of controlled release microspheres would ...

Cory Berkland. The University of Kansas. 在 ku.edu 的电子邮件经过验证. Drug DeliveryFormulationControlled Release. 文章引用次数开放获取的出版物 ...J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.The professors also say international students subsidize domestic students and if expelled from higher education in the states, colleges and universities - whose budgets have already been hit hard ...Dr. Kenneth L. Caldwell is a Orthopedist in Pasadena, TX. Find Dr. Caldwell's phone number, address, insurance information, hospital affiliations and more.

Cory Berkland. Corresponding Author. E-mail address: [email protected]. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047.

Abstract: Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles. Type: Grant. Filed: August 16, 2019. Date of Patent: February 14, 2023. Assignee: ADARE PHARMACEUTICALS USA, INC. Inventors: Cory Berkland, Milind Singh.A new pH-sensitive triblock copolymer, polyethylene glycol-block-poly(2-dimethylaminoethyl methacrylate)-block-poly(2-diisopropylaminoethyl methacrylate) (PEG-PDMA-PDPA), was synthesized via atom transfer radical polymerization (ATRP).The potential of this polymer for siRNA delivery was assessed. This triblock copolymer formed nanocapsules with high siRNA encapsulation efficiency that ...Nabil A Alhakamy, Ph.D. candidate (Co-advised with Dr. Cory Berkland) Lorena Antunez, Ph.D. candidate (Co-advised with Dr. Cory Berkland) Aishik Chakraborty, Ph.D. student Saba Ghazvini, Ph.D. student Rachel Hathaway, M.S. Under-Graduate Students. Kimberley Cole Erica Hui Monica Ketchum ...INTRODUCTION. Investigations into the molecular processes involved in antigen recognition have led to new approaches in the design and administration of vaccines (1, 2).Traditionally, vaccines generate a robust immune response to a particular antigen by adsorbing the antigen to an alum particle surface (3–5).Though individual alum particles …In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents. GI/ORAL. Citation: Dormer N, Berkland C, "Single-Step Functional Coatings for Increased Efficiencies". ONdrugDelivery Magazine, Issue 77 (Jul 2017), pp 28-31. In this article about oral drug innovation, Cory Berkland and Nathan Dormer focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this ...Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...May 5, 2019 · Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar] So Cory Berkland and colleagues set out to find new kinds of pharmaceuticals to fight weight gain. Targeting the body's process of absorbing fat, the researchers designed a class of polymers that capture fat particles called micelles in the intestines so they can't be digested. Instead, they pass through the gut and are excreted.PRECLINICAL STUDY The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin Fang • Min Yao • Iman Jokar • Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015

Alhakamy, Nabil A; Nigatu, Adane S; Berkland, Cory J et al. (2013) Noncovalently associated cell-penetrating peptides for gene delivery applications. Ther Deliv 4:741-57 Alhakamy, Nabil A; Berkland, Cory J (2013) Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. Mol Pharm 10:1940-8

Cory Berkland joins the faculty Nov. 1 from The University of Kansas, where he is the Solon E. Summerfield Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry. He has been on the faculty since 2003. In addition, he is the cofounder, chair and CEO of Bond Biosciences based in the Kansas City area; co ...

Nashwa El-Gendy, Mark M. Bailey, Cory Berkland; Pages 283-312. Liposomes for Pulmonary Drug Delivery. Janani Swaminathan, Carsten Ehrhardt; Pages 313-334. Nanoparticles for Pulmonary Delivery. Alan B. Watts, Robert O. Williams III; Pages 335-366. Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy.Cory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations. (Id. at 594) B. Defendants’ Experts.A Few Early Lessons in Entrepreneurship. Cory Berkland, Ph.D. Friday, September 1, 2017. 1:30 P.M.. Rawl Engineering Practice Facility, Room 200. Cory ...Jul 7, 2019 · Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas Introduction. Fibroblast growth factor-10 (FGF-10), also known as keratinocyte growth factor-2 (KGF-2), is a 208 amino acid polypeptide (M w 19,000) belonging to the FGF family. These structurally related proteins bind to polyanions including heparin and are involved in a variety of physiological and pathological processes [].FGF-10 activities include epithelial cell proliferation and ...Dr. Cory Berkland is Chairman of the Board, President, CEO, and Co-Founder of Bond Biosciences. He is Distinguished Professor at The University of Kansas and has extensive experience founding, growing, and exiting pharmaceutical companies including Orbis Biosciences and Savara Pharmaceuticals.Cory Berkland. The University of Kansas. 在 ku.edu 的电子邮件经过验证. Drug DeliveryFormulationControlled Release. 文章引用次数开放获取的出版物 ...Cory Berkland joins the faculty Nov. 1 from The University of Kansas, where he is the Solon E. Summerfield Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry. He has been on the faculty since 2003. In addition, he is the cofounder, chair and CEO of Bond Biosciences based in the Kansas City area; co ...C. Berkland et al. Precise control of PLG microsphere size provides enhanced control of drug release rate. J. Control. Release (2002) ... Cory Berkland. Protein Encapsulation in and Release from Monodisperse Double-Wall Polymer Microspheres. Journal of Pharmaceutical Sciences, Volume 102, Issue 5, 2013, pp. 1601-1609 ...If delivered as a suspension, such small particles are also prone to particle growth due to Ostwald ripening and can suffer from uncontrolled agglomeration (Berkland, 2010). A major obstacle to inhaled therapeutics is the inability to efficiently deliver large quantities of a drug to the deep lung (Gillian, 2010).Apr 5, 2022 · Cory Berkland, CEO [email protected]. Release Summary. Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Contacts.

Cory Berkland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).Cory Berkland. Download Free PDF View PDF. Nature Nanotechnology. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. 2012 • Ciro Chiappini, Michael Evangelopoulos, Lucas Isenhart, Ennio Tasciotti. Download Free PDF View PDF.Joe Scherrer. Executive Director, Henry Edwin Sever Institute Director, Cybersecurity Strategic Initiative Program Director, Graduate Studies in Cybersecurity Management.Cory Berkland, CEO [email protected] Release Summary Bond's clinical lead, BBI-001, is designed to rapidly and selectively bind dietary iron to reduce iron absorption in patients with iron overload.Instagram:https://instagram. volksstrumcraigslist maui puppiesmobile ball schedule 2023pslf loan forgiveness application ORCID record for Vivian Yudistyra. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities. training ciriculumkletc continuing education Cory BerklandDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Kansas, USA; [email protected] · ORCID Icon http ...Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science; get teacher certification online Europe PMC is an archive of life sciences journal literature.Cory Berkland, PhD, is the Solon E Summerfield Distinguished Professor at the University of Kansas, US. He is a co-founder and was Chief Scientific Officer of Orbis Biosciences (now Adare Pharmaceuticals) amongst other companies including Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Professor Berkland has a PhD in Chemical and ...